Observational Study on the Prophylactic Use of Curosurf in Neonatal Respiratory Distress Syndrome (RDS)

Chiesi Farmaceutici S.p.A.972 enrolled

Overview

The aim of Alizé is to describe a population of premature babies (gestational age (GA) \< 32 weeks) in real life situation and the management of RDS.

Description includes gestational age, birth clinical characteristics in particular the respiratory function, evaluation of the mother prenatal corticosteroids treatment in prophylaxis of RDS, mother medical and obstetric history, premature babies care in the delivery room with a special focus on the Curosurf use: prophylactic or curative use / other surfactant / no surfactant. A special focus is on the Prophylactic use.

Study Type

OBSERVATIONAL

Enrollment

972

Conditions

Respiratory Distress Syndrome, Newborn

Eligibility

Sex: ALLMin age: 1 MinuteMax age: 12 Hours

Medical Language ↔ Plain English

Inclusion Criteria: * during the study, each neonatologist will have to include all the babies born with a gestational age \< 32 GA Exclusion Criteria: * gestational age \> 32 GA * No consent to the data collection by one of the parents

Locations (1)

Laboratoire Chiesi S.A.

Courbevoie, France

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.